Reckitt Benckiser Nurofen owner Reckitt misses profit forecast amid tough trading Consumer goods group blames difficulties in developed markets and rising commodity costs The Nurofen-owning company has struggled with the weakest performance in its history. Photograph: Glenn Hunt/AAPReckitt Benckiser, the owner of brands including Durex and Nurofen, missed its 2017 profit expectations and said tough trading in developed markets and rising commodity costs were set to continue. Reckitt said pricing power tailed off over the past year, with large retail customers under pressure from online competitors. Like-for-like sales were flat for the full year, in line with the company’s forecast. For 2018, the company forecast revenue up 13-14%, with like-for-like sales up 2-3%.

Source: The Guardian February 19, 2018 14:52 UTC